Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma
| Autor: | Jan Stratmann, Michael Hogardt, Stefan Zeuzem, Mate Knabe, Phillip G. Ferstl, Olivier Ballo, Vera Himmelsbach, Kai-Henrik Peiffer, Volkhard A. J. Kempf, Thomas A. Wichelhaus, Oliver Waidmann, Fabian Finkelmeier |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Cancer Research
medicine.medical_specialty Cirrhosis Carcinoma Hepatocellular Gastroenterology 03 medical and health sciences Liver disease 0302 clinical medicine Risk Factors Internal medicine Drug Resistance Multiple Bacterial medicine Humans Stage (cooking) Risk factor Retrospective Studies Hematology business.industry Liver Neoplasms Retrospective cohort study General Medicine medicine.disease digestive system diseases Anti-Bacterial Agents Oncology 030220 oncology & carcinogenesis Hepatocellular carcinoma 030211 gastroenterology & hepatology Liver cancer business |
| Zdroj: | Journal of cancer research and clinical oncology. 148(6) |
| ISSN: | 1432-1335 |
| Popis: | Introduction MDRO-colonization has been shown to impair survival in patients with hematological malignancies and solid tumors as well as in patients with liver disease. Despite the increasing spread of multidrug-resistant organisms (MDRO), its impact on patients with hepatocellular carcinoma (HCC) has not been studied. We conducted this retrospective study to analyze the impact of MDRO-colonization on overall prognosis in HCC patients. Materials and methods All patients with confirmed HCC diagnosed between January 2008 and December 2017 at the University Hospital Frankfurt were included in this study. HCC patients with a positive MDRO screening before or within the first 90 days after diagnosis of HCC were defined as colonized HCC patients, HCC patients with a negative MDRO screening were defined as noncolonized HCC patients. Results 59 (6%) colonized and 895 (94%) noncolonized HCC patients were included. Enterobacterales with extended-spectrum β-lactamase-like phenotype with or without resistance to fluoroquinolones (ESBL/ ± FQ) were the most frequently found MDRO with 59%, followed by vancomycin-resistant Enterococcus faecium with 37%. Colonized HCC patients had more severe cirrhosis and more advanced HCC stage compared to noncolonized HCC patients. Colonized HCC patients showed an impaired survival with a median OS of 189 days (6.3 months) compared to a median OS of 1001 days (33.4 months) in noncolonized HCC patients. MDRO-colonization was identified as an independent risk factor associated with survival in multivariate analysis. Conclusion MDRO-colonization is an independent risk factor for survival in patients with HCC highlighting the importance of regular MDRO screening, isolation measures as well as interdisciplinary antibiotic steward-ship programs to guide responsible use of antibiotic agents. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink